MedPath

NAFLD Study: US vs Liver Biopsy

Not Applicable
Conditions
Non-Alcoholic Fatty Liver Disease
Interventions
Diagnostic Test: shear waves elastography; liver biopsy
Registration Number
NCT04101162
Lead Sponsor
University of Roma La Sapienza
Brief Summary

Evaluate the diagnostic accuracy of the new ultrasound software vs hepatic histology, the current reference standard for the diagnosis of NAFLD and NASH in 20 obese patients (BMI\> 30) candidates for laparoscopic bariatric surgery and / or cholecystectomy

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
20
Inclusion Criteria
  1. Patients who are candidates for bariatric surgery between the ages of 18 and 65,

    • BMI> 40 kg / m2, in the absence of any other comorbidity
    • BMI> 35 kg / m2, in the presence of comorbidities among those classically considered to be associated with obesity
    • ICM> 30 kg / m2, in the presence of T2DM not in glycometabolic compensation
  2. Patients who are candidates for laparoscopic cholecystectomy for symptomatic calculi with BMI> 30

Exclusion Criteria
  • Age ≤ 18 or ≥ 65
  • Any concurrent surgical procedure except cholecystectomy and hiatal hernia repair
  • Conversion into laparotomy surgery
  • Post-operative complications requiring new surgical treatment
  • Patient not compliant in the follow-up

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ATIshear waves elastography; liver biopsy-
liver biopsyshear waves elastography; liver biopsy-
Primary Outcome Measures
NameTimeMethod
diagnostic accurancy of ATI in obese patients6 months

a new ultrasound software compared with liver biopsy in obese patients.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

ICOT Latina

🇮🇹

Latina, LT, Italy

© Copyright 2025. All Rights Reserved by MedPath